ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lacosamide Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17B15755
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lacosamide Injection Market Research Report 2023
BUY CHAPTERS

Global Lacosamide Injection Market Research Report 2025

Code: QYRE-Auto-17B15755
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
UCB Pharma Limited
Camber Pharmaceuticals
Chengdu Lier Pharmaceutical Co., Ltd.
Jiangsu Haian Pharmaceutical Co., Ltd.
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Jiangxi Kerui Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
Hefei Yifan Biopharmaceuticals Inc.
Fresenius Kabi

Lacosamide Injection Market

The global market for Lacosamide Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Lacosamide Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lacosamide Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lacosamide Injection include Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc., Jiangsu Haian Pharmaceutical Co., Ltd., Jiangxi Kerui Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Camber Pharmaceuticals, Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lacosamide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacosamide Injection.
The Lacosamide Injection market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lacosamide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lacosamide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lacosamide Injection Market Report

Report Metric Details
Report Name Lacosamide Injection Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc., Jiangsu Haian Pharmaceutical Co., Ltd., Jiangxi Kerui Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Camber Pharmaceuticals, Fresenius Kabi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lacosamide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lacosamide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Lacosamide Injection Market report?

Ans: The main players in the Lacosamide Injection Market are Shijiazhuang No.4 Pharmaceutical Co., Ltd., Chengdu Lier Pharmaceutical Co., Ltd., Hefei Yifan Biopharmaceuticals Inc., Jiangsu Haian Pharmaceutical Co., Ltd., Jiangxi Kerui Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Camber Pharmaceuticals, Fresenius Kabi

What are the Application segmentation covered in the Lacosamide Injection Market report?

Ans: The Applications covered in the Lacosamide Injection Market report are Hospital, Retail Drug Store, Online Sales, Others

What are the Type segmentation covered in the Lacosamide Injection Market report?

Ans: The Types covered in the Lacosamide Injection Market report are Generic Drug, Original Drug

Recommended Reports

Pharmaceutical Injections

Therapeutics & Treatments

Diagnostics & Vaccines

1 Lacosamide Injection Market Overview
1.1 Product Definition
1.2 Lacosamide Injection by Type
1.2.1 Global Lacosamide Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Lacosamide Injection by Application
1.3.1 Global Lacosamide Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Drug Store
1.3.4 Online Sales
1.3.5 Others
1.4 Global Lacosamide Injection Market Size Estimates and Forecasts
1.4.1 Global Lacosamide Injection Revenue 2020-2031
1.4.2 Global Lacosamide Injection Sales 2020-2031
1.4.3 Global Lacosamide Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lacosamide Injection Market Competition by Manufacturers
2.1 Global Lacosamide Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lacosamide Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lacosamide Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lacosamide Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lacosamide Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lacosamide Injection, Product Type & Application
2.7 Global Key Manufacturers of Lacosamide Injection, Date of Enter into This Industry
2.8 Global Lacosamide Injection Market Competitive Situation and Trends
2.8.1 Global Lacosamide Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lacosamide Injection Players Market Share by Revenue
2.8.3 Global Lacosamide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lacosamide Injection Market Scenario by Region
3.1 Global Lacosamide Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lacosamide Injection Sales by Region: 2020-2031
3.2.1 Global Lacosamide Injection Sales by Region: 2020-2025
3.2.2 Global Lacosamide Injection Sales by Region: 2026-2031
3.3 Global Lacosamide Injection Revenue by Region: 2020-2031
3.3.1 Global Lacosamide Injection Revenue by Region: 2020-2025
3.3.2 Global Lacosamide Injection Revenue by Region: 2026-2031
3.4 North America Lacosamide Injection Market Facts & Figures by Country
3.4.1 North America Lacosamide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lacosamide Injection Sales by Country (2020-2031)
3.4.3 North America Lacosamide Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lacosamide Injection Market Facts & Figures by Country
3.5.1 Europe Lacosamide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lacosamide Injection Sales by Country (2020-2031)
3.5.3 Europe Lacosamide Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lacosamide Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Lacosamide Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lacosamide Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Lacosamide Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lacosamide Injection Market Facts & Figures by Country
3.7.1 Latin America Lacosamide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lacosamide Injection Sales by Country (2020-2031)
3.7.3 Latin America Lacosamide Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lacosamide Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Lacosamide Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lacosamide Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lacosamide Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lacosamide Injection Sales by Type (2020-2031)
4.1.1 Global Lacosamide Injection Sales by Type (2020-2025)
4.1.2 Global Lacosamide Injection Sales by Type (2026-2031)
4.1.3 Global Lacosamide Injection Sales Market Share by Type (2020-2031)
4.2 Global Lacosamide Injection Revenue by Type (2020-2031)
4.2.1 Global Lacosamide Injection Revenue by Type (2020-2025)
4.2.2 Global Lacosamide Injection Revenue by Type (2026-2031)
4.2.3 Global Lacosamide Injection Revenue Market Share by Type (2020-2031)
4.3 Global Lacosamide Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lacosamide Injection Sales by Application (2020-2031)
5.1.1 Global Lacosamide Injection Sales by Application (2020-2025)
5.1.2 Global Lacosamide Injection Sales by Application (2026-2031)
5.1.3 Global Lacosamide Injection Sales Market Share by Application (2020-2031)
5.2 Global Lacosamide Injection Revenue by Application (2020-2031)
5.2.1 Global Lacosamide Injection Revenue by Application (2020-2025)
5.2.2 Global Lacosamide Injection Revenue by Application (2026-2031)
5.2.3 Global Lacosamide Injection Revenue Market Share by Application (2020-2031)
5.3 Global Lacosamide Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd.
6.1.1 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Information
6.1.2 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolio
6.1.5 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Chengdu Lier Pharmaceutical Co., Ltd.
6.2.1 Chengdu Lier Pharmaceutical Co., Ltd. Company Information
6.2.2 Chengdu Lier Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolio
6.2.5 Chengdu Lier Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Hefei Yifan Biopharmaceuticals Inc.
6.3.1 Hefei Yifan Biopharmaceuticals Inc. Company Information
6.3.2 Hefei Yifan Biopharmaceuticals Inc. Description and Business Overview
6.3.3 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product Portfolio
6.3.5 Hefei Yifan Biopharmaceuticals Inc. Recent Developments/Updates
6.4 Jiangsu Haian Pharmaceutical Co., Ltd.
6.4.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
6.4.2 Jiangsu Haian Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolio
6.4.5 Jiangsu Haian Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Jiangxi Kerui Pharmaceutical Co., Ltd.
6.5.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
6.5.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product Portfolio
6.5.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
6.6.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
6.6.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Business Overview
6.6.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product Portfolio
6.6.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
6.7 UCB Pharma Limited
6.7.1 UCB Pharma Limited Company Information
6.7.2 UCB Pharma Limited Description and Business Overview
6.7.3 UCB Pharma Limited Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 UCB Pharma Limited Lacosamide Injection Product Portfolio
6.7.5 UCB Pharma Limited Recent Developments/Updates
6.8 Camber Pharmaceuticals
6.8.1 Camber Pharmaceuticals Company Information
6.8.2 Camber Pharmaceuticals Description and Business Overview
6.8.3 Camber Pharmaceuticals Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Camber Pharmaceuticals Lacosamide Injection Product Portfolio
6.8.5 Camber Pharmaceuticals Recent Developments/Updates
6.9 Fresenius Kabi
6.9.1 Fresenius Kabi Company Information
6.9.2 Fresenius Kabi Description and Business Overview
6.9.3 Fresenius Kabi Lacosamide Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Fresenius Kabi Lacosamide Injection Product Portfolio
6.9.5 Fresenius Kabi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lacosamide Injection Industry Chain Analysis
7.2 Lacosamide Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lacosamide Injection Production Mode & Process Analysis
7.4 Lacosamide Injection Sales and Marketing
7.4.1 Lacosamide Injection Sales Channels
7.4.2 Lacosamide Injection Distributors
7.5 Lacosamide Injection Customer Analysis
8 Lacosamide Injection Market Dynamics
8.1 Lacosamide Injection Industry Trends
8.2 Lacosamide Injection Market Drivers
8.3 Lacosamide Injection Market Challenges
8.4 Lacosamide Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
UCB Pharma Limited
Camber Pharmaceuticals
Chengdu Lier Pharmaceutical Co., Ltd.
Jiangsu Haian Pharmaceutical Co., Ltd.
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Jiangxi Kerui Pharmaceutical Co., Ltd.
Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
Hefei Yifan Biopharmaceuticals Inc.
Fresenius Kabi
List of Tables
 Table 1. Global Lacosamide Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lacosamide Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lacosamide Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lacosamide Injection Sales (K Boxes) of Key Manufacturers (2020-2025)
 Table 5. Global Lacosamide Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lacosamide Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lacosamide Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lacosamide Injection Average Price (US$/Box) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lacosamide Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lacosamide Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lacosamide Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Lacosamide Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lacosamide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lacosamide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lacosamide Injection Sales by Region (2020-2025) & (K Boxes)
 Table 18. Global Lacosamide Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Lacosamide Injection Sales by Region (2026-2031) & (K Boxes)
 Table 20. Global Lacosamide Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Lacosamide Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lacosamide Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Lacosamide Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lacosamide Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Lacosamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lacosamide Injection Sales by Country (2020-2025) & (K Boxes)
 Table 27. North America Lacosamide Injection Sales by Country (2026-2031) & (K Boxes)
 Table 28. North America Lacosamide Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lacosamide Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lacosamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lacosamide Injection Sales by Country (2020-2025) & (K Boxes)
 Table 32. Europe Lacosamide Injection Sales by Country (2026-2031) & (K Boxes)
 Table 33. Europe Lacosamide Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lacosamide Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lacosamide Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lacosamide Injection Sales by Region (2020-2025) & (K Boxes)
 Table 37. Asia Pacific Lacosamide Injection Sales by Region (2026-2031) & (K Boxes)
 Table 38. Asia Pacific Lacosamide Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lacosamide Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lacosamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lacosamide Injection Sales by Country (2020-2025) & (K Boxes)
 Table 42. Latin America Lacosamide Injection Sales by Country (2026-2031) & (K Boxes)
 Table 43. Latin America Lacosamide Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lacosamide Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lacosamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lacosamide Injection Sales by Country (2020-2025) & (K Boxes)
 Table 47. Middle East and Africa Lacosamide Injection Sales by Country (2026-2031) & (K Boxes)
 Table 48. Middle East and Africa Lacosamide Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lacosamide Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lacosamide Injection Sales (K Boxes) by Type (2020-2025)
 Table 51. Global Lacosamide Injection Sales (K Boxes) by Type (2026-2031)
 Table 52. Global Lacosamide Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Lacosamide Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Lacosamide Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lacosamide Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lacosamide Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Lacosamide Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Lacosamide Injection Price (US$/Box) by Type (2020-2025)
 Table 59. Global Lacosamide Injection Price (US$/Box) by Type (2026-2031)
 Table 60. Global Lacosamide Injection Sales (K Boxes) by Application (2020-2025)
 Table 61. Global Lacosamide Injection Sales (K Boxes) by Application (2026-2031)
 Table 62. Global Lacosamide Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Lacosamide Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Lacosamide Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lacosamide Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lacosamide Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Lacosamide Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Lacosamide Injection Price (US$/Box) by Application (2020-2025)
 Table 69. Global Lacosamide Injection Price (US$/Box) by Application (2026-2031)
 Table 70. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Company Information
 Table 71. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 73. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Lacosamide Injection Product
 Table 74. Shijiazhuang No.4 Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Chengdu Lier Pharmaceutical Co., Ltd. Company Information
 Table 76. Chengdu Lier Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 78. Chengdu Lier Pharmaceutical Co., Ltd. Lacosamide Injection Product
 Table 79. Chengdu Lier Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Hefei Yifan Biopharmaceuticals Inc. Company Information
 Table 81. Hefei Yifan Biopharmaceuticals Inc. Description and Business Overview
 Table 82. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 83. Hefei Yifan Biopharmaceuticals Inc. Lacosamide Injection Product
 Table 84. Hefei Yifan Biopharmaceuticals Inc. Recent Developments/Updates
 Table 85. Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
 Table 86. Jiangsu Haian Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 88. Jiangsu Haian Pharmaceutical Co., Ltd. Lacosamide Injection Product
 Table 89. Jiangsu Haian Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
 Table 91. Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 93. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Injection Product
 Table 94. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
 Table 96. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Business Overview
 Table 97. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 98. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Injection Product
 Table 99. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
 Table 100. UCB Pharma Limited Company Information
 Table 101. UCB Pharma Limited Description and Business Overview
 Table 102. UCB Pharma Limited Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 103. UCB Pharma Limited Lacosamide Injection Product
 Table 104. UCB Pharma Limited Recent Developments/Updates
 Table 105. Camber Pharmaceuticals Company Information
 Table 106. Camber Pharmaceuticals Description and Business Overview
 Table 107. Camber Pharmaceuticals Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 108. Camber Pharmaceuticals Lacosamide Injection Product
 Table 109. Camber Pharmaceuticals Recent Developments/Updates
 Table 110. Fresenius Kabi Company Information
 Table 111. Fresenius Kabi Description and Business Overview
 Table 112. Fresenius Kabi Lacosamide Injection Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 113. Fresenius Kabi Lacosamide Injection Product
 Table 114. Fresenius Kabi Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Lacosamide Injection Distributors List
 Table 118. Lacosamide Injection Customers List
 Table 119. Lacosamide Injection Market Trends
 Table 120. Lacosamide Injection Market Drivers
 Table 121. Lacosamide Injection Market Challenges
 Table 122. Lacosamide Injection Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lacosamide Injection
 Figure 2. Global Lacosamide Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lacosamide Injection Market Share by Type: 2024 & 2031
 Figure 4. Generic Drug Product Picture
 Figure 5. Original Drug Product Picture
 Figure 6. Global Lacosamide Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lacosamide Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Retail Drug Store
 Figure 10. Online Sales
 Figure 11. Others
 Figure 12. Global Lacosamide Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Lacosamide Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Lacosamide Injection Sales (2020-2031) & (K Boxes)
 Figure 15. Global Lacosamide Injection Average Price (US$/Box) & (2020-2031)
 Figure 16. Lacosamide Injection Report Years Considered
 Figure 17. Lacosamide Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Lacosamide Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Lacosamide Injection Players: Market Share by Revenue in Lacosamide Injection in 2024
 Figure 20. Lacosamide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Lacosamide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Lacosamide Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Lacosamide Injection Revenue Market Share by Country (2020-2031)
 Figure 24. United States Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Lacosamide Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Lacosamide Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Lacosamide Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Lacosamide Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Lacosamide Injection Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Lacosamide Injection Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Lacosamide Injection Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Lacosamide Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Lacosamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Lacosamide Injection by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Lacosamide Injection by Type (2020-2031)
 Figure 54. Global Lacosamide Injection Price (US$/Box) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Lacosamide Injection by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Lacosamide Injection by Application (2020-2031)
 Figure 57. Global Lacosamide Injection Price (US$/Box) by Application (2020-2031)
 Figure 58. Lacosamide Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Lixisenatide Injection Market Research Report 2024
Etamsylate Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Special Injection Market Research Report 2025
Global Tislelizumab Injection Market Research Report 2024
Global Iopromide Injection Market Research Report 2024
Global Eye Injection Market Research Report 2024
Global Maltose Injection Market Research Report 2024
Global Bevacizumab Injection Market Research Report 2024
Ceftazidime for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Compound Mannitol Injection Market Research Report 2024
Global Aprepitant Injection Market Research Report 2025
Global Cyclophosphamide for Injection Market Research Report 2024
Global Morphine Sulfate Injection Market Research Report 2024
Global Tobramycin Sulfate Injection Market Research Report 2024
Global Self Injections Market Research Report 2024
Global Sterile Injection Development Market Research Report 2025
Global Small Molecule Injectable Market Research Report 2024
Generic Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ivonescimab Injection Market Research Report 2024
Global Injection Medicine Bottle Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions